Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

26 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
EXclusion of non-Involved uterus from the Target Volume (EXIT-trial): an individualized treatment for locally advanced cervical cancer using modern radiotherapy and imaging techniques.
Vandecasteele K, Tummers P, Van Bockstal M, De Visschere P, Vercauteren T, De Gersem W, Denys H, Naert E, Makar A, De Neve W. Vandecasteele K, et al. Among authors: naert e. BMC Cancer. 2018 Sep 17;18(1):898. doi: 10.1186/s12885-018-4800-0. BMC Cancer. 2018. PMID: 30223802 Free PMC article. Clinical Trial.
PRIMMO study protocol: a phase II study combining PD-1 blockade, radiation and immunomodulation to tackle cervical and uterine cancer.
Tuyaerts S, Van Nuffel AMT, Naert E, Van Dam PA, Vuylsteke P, De Caluwé A, Aspeslagh S, Dirix P, Lippens L, De Jaeghere E, Amant F, Vandecasteele K, Denys H. Tuyaerts S, et al. Among authors: naert e. BMC Cancer. 2019 May 28;19(1):506. doi: 10.1186/s12885-019-5676-3. BMC Cancer. 2019. PMID: 31138229 Free PMC article. Clinical Trial.
Splenic 18F-FDG uptake on baseline PET/CT is associated with oncological outcomes and tumor immune state in uterine cervical cancer.
De Jaeghere EA, Laloo F, Lippens L, Van Bockstal M, De Man K, Naert E, Van Dorpe J, Van de Vijver K, Tummers P, Makar A, De Visschere PJL, De Wever O, Amant F, Denys HG, Vandecasteele K. De Jaeghere EA, et al. Among authors: naert e. Gynecol Oncol. 2020 Nov;159(2):335-343. doi: 10.1016/j.ygyno.2020.08.001. Epub 2020 Aug 25. Gynecol Oncol. 2020. PMID: 32859399
A clearer view on ovarian clear cell carcinoma.
De Pauw A, Naert E, Van de Vijver K, Philippe T, Vandecasteele K, Denys H. De Pauw A, et al. Among authors: naert e. Acta Clin Belg. 2022 Aug;77(4):792-804. doi: 10.1080/17843286.2021.1964051. Epub 2021 Aug 17. Acta Clin Belg. 2022. PMID: 34404331
Safety of pre- or postoperative accelerated radiotherapy in 5 fractions: A randomized pilot trial.
Vakaet V, Van Hulle H, Van de Vijver K, Hilderson I, Naert E, De Neve W, Vandorpe J, Hendrix A, Göker M, Depypere H, Vergauwen G, Van den Broecke R, De Visschere P, Braems G, Vandecasteele K, Denys H, Veldeman L. Vakaet V, et al. Among authors: naert e. Breast. 2022 Apr;62:10-15. doi: 10.1016/j.breast.2022.01.010. Epub 2022 Jan 20. Breast. 2022. PMID: 35091184 Free PMC article. Clinical Trial.
Mental Health and Quality of Life among Patients with Cancer during the SARS-CoV-2 Pandemic: Results from the Longitudinal ONCOVID Survey Study.
De Jaeghere EA, Kanervo H, Colman R, Schrauwen W, West P, Vandemaele N, De Pauw A, Jacobs C, Hilderson I, Saerens M, Sundahl N, Vandecasteele K, Naert E, Lapeire L, Kruse V, Rottey S, Lemmens G, Denys HG. De Jaeghere EA, et al. Among authors: naert e. Cancers (Basel). 2022 Feb 21;14(4):1093. doi: 10.3390/cancers14041093. Cancers (Basel). 2022. PMID: 35205838 Free PMC article.
Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma: Results of the phase II PRIMMO study.
De Jaeghere EA, Tuyaerts S, Van Nuffel AMT, Belmans A, Bogaerts K, Baiden-Amissah R, Lippens L, Vuylsteke P, Henry S, Trinh XB, van Dam PA, Aspeslagh S, De Caluwé A, Naert E, Lambrechts D, Hendrix A, De Wever O, Van de Vijver KK, Amant F, Vandecasteele K, Denys HG. De Jaeghere EA, et al. Among authors: naert e. Cancer Immunol Immunother. 2023 Feb;72(2):475-491. doi: 10.1007/s00262-022-03253-x. Epub 2022 Aug 12. Cancer Immunol Immunother. 2023. PMID: 35960332 Free PMC article. Clinical Trial.
26 results